Evidence map›Paper›PMID 39021667›Full record

ArticleRadiology case reports2024

An unusual case of ureteric stricture post robotic partial nephrectomy of a renal mass managed by Memokath insertion.

Ahmed Haroon, Nagy Younes, Khalid El-Sayid, Malkan Khatib, Ibrahim A Khalil, Jamil Ahmad, Omar M Abomarzouk, Khalid Al-Rumaihi, Abdulla Al-Ansari

Abstract readCase Reports
PubMed Full text at PMC Publisher
In one paragraph

Article in Radiology case reports, 2024. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.

0numbers the graph read from it
0cells of the map it votes in
1citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

1 citing paper in PubMed.

  1. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

9 authors.

Ahmed HaroonDepartment of Urology, Hamad Medical Corporation, Doha, Qatar.
Nagy YounesDepartment of Urology, Hamad Medical Corporation, Doha, Qatar.
Khalid El-SayidDepartment of Urology, Hamad Medical Corporation, Doha, Qatar.
Malkan KhatibDepartment of Urology, Hamad Medical Corporation, Doha, Qatar.
Ibrahim A KhalilDepartment of Urology, Hamad Medical Corporation, Doha, Qatar.
Jamil AhmadDepartment of Urology, Hamad Medical Corporation, Doha, Qatar.
Omar M AbomarzoukDepartment of Surgery, Surgical Research Section, Hamad Medical Hospital, Hamad Medical Corporation, Doha, Qatar.
Khalid Al-RumaihiDepartment of Urology, Hamad Medical Corporation, Doha, Qatar.
Abdulla Al-AnsariDepartment of Urology, Hamad Medical Corporation, Doha, Qatar.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Robotic assisted partial nephrectomy is the gold standard treatment for small renal masses. Ureteric stricture is a rare but serious complication that significantly increase the morbidity and worsens the quality of life for cancer patients. Definitive treatment such as surgical reconstruction or ureteroureterostomy is not always feasible as in patients with significant morbidity or high-risk patients. Other options include ureteric double J stent or nephrostomy tube placement with regular exchange. We present a case of iatrogenic upper ureteric stricture post robotic assisted partial nephrectomy for right renal mass that was discovered on postoperative follow up imaging treated with metallic ureteral stent (Memokath) as reconstructive surgery was difficult due to proximity to the tumor bed. We found that if reconstructive surgery is not feasible, metallic ureteral stents has good durability, better quality of life than ureteric double stents for the management of ureteric stricture.

Indexed as

Case reportIatrogenic strictureMemokathRobotic assisted partial nephrectomySmall renal massUreteric stricture

Identifiers

PMID39021667
PMCPMC11253136

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.